Skip to main content
. 2020 Feb 3;2020:6574010. doi: 10.1155/2020/6574010

Table 2.

ALB ± SD (U/l) among the studied groups after 3 weeks, 6 weeks, and 9 weeks.

Albumin ALB (U/l) (3 weeks) ALB (U/l) (6 weeks) ALB (U/l) (9 weeks) Paired t-test
P 1 P 2 P 3
Control 4.07 ± 0.13 4.06 ± 0.09 4.08 ± 0.09 t 1 = 0.25
P1 = 0.81
t 2 = 0.43
P2 = 0.68
t 3 = 0.56
P3 = 0.59
CCl4 3.86 ± 0.30 2.98 ± 0.49 2.42 ± 0.64 t 1 = 4.36
P1 = 0.002
t 2 = 6.02
P2 ≤ 0.001
t 3 = 2.18
P3 = 0.06
Free media 3.80 ± 0.31 2.88 ± 0.50 2.47 ± 0.60 t 1 = 4.27
P1 = 0.002
t 2 = 4.84
P2 = 0.001
t 3 = 1.93
P3 = 0.08
CCl4+Nilotinib 3.93 ± 0.20 3.48 ± 0.46 3.28 ± 0.69 t 1 = 2.58
P1 = 0.03
t 2 = 2.61
P2 = 0.028
t 3 = 0.76
P3 = 0.46
CCl4+stem cell exosomes 3.95 ± 0.19 3.14 ± 0.53 3.07 ± 0.40 t 1 = 4.38
P1 = 0.002
t 2 = 7.17
P2 ≤ 0.001
t 3 = 0.32
P3 = 0.75
CCl4+stem cell exosomes+Nilotinib 3.97 ± 0.14 3.69 ± 0.35 3.88 ± 0.36 t 1 = 2.26
P1 = 0.05
t 2 = 0.64
P2 = 0.54
t 3 = 1.09
P3 = 0.30
ANOVA test 1.679 10.96 18.38
P value 0.155 <0.001 <0.001